European and UK Health Authority Officials, Industry Leaders, Notified Body Reps, Other Experts to Speak at RAPS’ Europe Conference

RAPSRAPS' LatestRAPS AnnouncementsRAPS Announcements | 24 April 2019 |  By 

RAPS released the updated agenda for its upcoming European conference in Brussels, 13–14 May. Among the speakers for the inaugural RAPS Regulatory Conference – Europe 2019 are representatives from the European authorities, notified bodies and trade representatives, all thought leaders and stakeholders with crucial responsibilities in the effective implementation and functioning of the changing European regulatory environment.

“Europe’s regulatory environment for medicines and medical technology is always evolving but we are now going through a period of major transition,” said RAPS Executive Director Paul Brooks. “The new Medical Device and IVD Regulations, impacts on pharmaceutical manufacturers of combination products and the uncertain future of Brexit present a unique and complex set of challenges for the European life sciences sector. It is vital for all stakeholders to engage in productive and informed dialogue. This conference presents an opportunity for regulators, thought leaders and regulatory professionals to come together to discuss the critical questions, practical implications and important steps ahead.”

Conference speakers include:
  • Erik Hansson, European Commission
  • Bassil Akra, TÜV SÜD Product Service GmbH
  • Olivier Bisazza, MedTech Europe
  • Sabina L. Hoekstra-van den Bosch, Central Committee for Research Involving Human Subjects
  • Graeme Tunbridge, MHRA
  • Valerie Nys, Federal Agency of Medicines and Health Products
  • Maren von Fritschen, PhD, European Confederation of Pharmaceutical Entrepreneurs
  • Henrike Potthast, BfArM
  • Corine Delorme, GMED Group LNE
  • Marie-Helene Pinheiro, EMA
  • Andreas Stange, TÜV SÜD Product Service GmbH
  • Armin Ritzhaupt, EMA
  • Tim De Schutter, Federal Agency of Medicines and Health Products
  • Kees Maqueline, Afdeling Medische Technoligie
  • Katrien Martens, Federal Agency of Medicines and Health Products
  • Waldo Weijers, Medicines Evaluation Board (NL)
For more information or to register for the RAPS Regulatory Conference – Europe 2019, click here


© 2023 Regulatory Affairs Professionals Society.

Discover more of what matters to you

No taxonomy